Optimization of BR-8 synthesis

Łukasz S. Kaczmarek 1Andrzej Leś 1,2Łukasz Mucha 1Katarzyna Badowska-Rosłonek 1Justyna Kowalska 1Anna Rosa 1

1. Pharmaceutical Research Institute (IF), Rydygiera 8, Warszawa 01-793, Poland
2. University of Warsaw, Faculty of Chemistry, Żwirki i Wigury 101, Warszawa 02-089, Poland

Abstract

The key step of the BR-8 API synthesis is the SN2 type reaction of BR-7, in witch the sulfonate group is substituted with ethylamine, to give an aminoderivative with inverse configuration:

The reaction was carried out at laboratory scale under various conditionsin order to achieve high yield and purity of the product. The reaction parameters were sampled into full 32 factorial experiment (type of the leaving substituent; the solvent used as a medium) and then following a series of four consecutive screenings of excess of amine and temperature of the reaction following one-dimensional search (keeping one variable constant and changing the other). Molar content of the crude reaction product was found with the use of the mass balance and the corresponding HPLC parameters. Based on the predicted molar content of reaction mixtures a series of reaction response surfaces was calculated. From analysis of original experimental data and the response surfaces it appears that there exists an optimal set of reaction parameters for BR-8 synthesis securing a high conversion ratio of about 80% yield and 97% purity of the crude product.

 

Related papers
  1. Ethical and generic drugs
  2. Synthesis of new 5H-indolo[2,3-b]quinoline derivatives with a high selective cytotoxic activity
  3. Hplc study of Cilostazol tablets: assay and release profile determination
  4. Bioequivalence study of ondansetron film-coated tablets in healthy volunteers
  5. Validation of HPLC methods for analyzing the chemical purity of cilostazol
  6. Identification of degradation products of cilostazol drug substance
  7. Capecitabine molecular structure in the liquid state as predicted from NMR measurements and theoretical calculations.
  8. Comparison of bisoprolol pharmacokinetics after 10 mg oral administration of Bisocard and reference formulation to healthy subjects
  9. Bioequivalence study of 500 mg cefuroxime film-coated tablets in healthy volunteers
  10. Development and validation of the HPLC-UV method for impurities determination in duloxetine hydrochloride
  11. 5H-indolo-[2,3-b]quinolines loaded polymeric micelles
  12. HPLC methods for in–process control and chemical purity determination of olopatadine
  13. Efficient preparation of a key intermediate in the exemestane synthesis
  14. HPLC method for determination of the enantiomeric purity of a new ω chain aldehyde synthon used in the synthesis of travoprost
  15. Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents. 
  16. Determination of reaction progress in synthesis of EE-3 by NMR technique
  17. Analytical control of synthesis and determination of BR-S by HPLC
  18. Opimisation of preparation of TZ-6
  19. HPLC method as an analitycal control of synthesis and determination of TZ-S
  20. HPLC Methods for Stress Testing of ZL-S Drug Substances
  21. New amino acid and peptide derivatives of 5H-indolo[2,3-b]quinoline and their biological activity.
  22. Zolmitriptan synthesis and in-process control by HPLC methods
  23. The cytotoxic activity of glycosides of indolo[2,3-b]quinoline derivatives.
  24. HPLC as a method for analytical control of synthesis and determination of tolterodine (TD-S)
  25. Application of confidence intervals to bioanalytical method validation
  26. Searching for lead molecules as potential new CNS agents in the serotonin 5-HT6 screening assay
  27. Development of HPLC and GC methods for analysis of Zolmitriptan of pharmaceutical purity
  28. Optimization of AR-3 synthesis
  29. New amino acid derivatives of 6H-indolo[2,3-b]quinolines
  30. CHARACTERIZATION OF ARIPIPRAZOLE SOLVATE WITH ETHANOL AND POLYMORPHIC FORMS PRODUCED DURING ITS HEATING
  31. HPLC SEPARATION AND DETERMINATION OF ZIPRASIDONE
  32. SYNTHESIS OF GLIMEPIRIDE - CRYSTAL STRUCTURE ANALYSIS STEP BY STEP
  33. THE CYTOTOXIC GLYCOSIDES OF INDOLO[2,3-B]QUINOLINE DERIVATIVES. IN VITRO AND IN VIVO STUDIES
  34. SYNTHESIS OF PIOGLITAZONE HYDROCHLORIDE OF PHARMACEUTICAL PURITY AT SMALL PLANT SCALE
  35. 1H AND 13C NMR DATA FOR INDOLO[2,3-b]QUINOLINES - AMINOGLYCOSIDE HYBRIDS, A NOVEL POTENT ANTICANCER DRUG FAMILY .
  36. NEW SYNTHESIS OF 11-(1-PIPERAZINYL)- DIBENZO[b,f][1,4]THIAZEPINE, A CRUCIAL INTERMEDIATE IN QUETIAPINE PRODUCTION.

Presentation: Poster at VII Multidyscyplinarna Konferencja Nauki o Leku, by Łukasz S. Kaczmarek
See On-line Journal of VII Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2010-03-17 11:09
Revised:   2010-04-01 10:16